国产品牌,进口替代,不担心高关税

产品中心 抗体 配对抗体

所有图片(1/1)

IL-28B/IFN-λ3 Recombinant Rabbit mAb (SDT-1838-77-2)

货号: S0B3407

Datasheet
  • 价格: ¥7,500
  • 规格:
  • 数量:
斯达特大包装询价 大包装询价

产品介绍 引用文献(0) 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    IL-28B/IFN-λ3
  • 免疫原

    Recombinant Protein
  • 克隆号

    SDT-1838-77-2
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 应用

    Sandwich ELISA
  • 反应种属 ?

    Hu
  • 交叉反应

    No cross-reactivity against IL-28A, IL-29, IL-10

  • 纯化方式

    Protein A
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt, 2 to 8 °C as supplied

  • 稀释度

    [{"application": "ELISA", "dilution": "", "species": ""}, {"application": "Sandwich ELISA", "dilution": "", "species": ""}, {"application": "CLIA", "dilution": "", "species": ""}, {"application": "Lateral Flow", "dilution": "", "species": ""}, {"application": "Dot Blot", "dilution": "", "species": ""}, {"application": "WB", "dilution": "", "species": ""}, {"application": "IP", "dilution": "", "species": ""}, {"application": "IHC-P", "dilution": "", "species": ""}, {"application": "ICC", "dilution": "", "species": ""}, {"application": "IF", "dilution": "", "species": ""}, {"application": "ICFCM", "dilution": "", "species": ""}, {"application": "FCM", "dilution": "", "species": ""}, {"application": "mIHC", "dilution": "", "species": ""}, {"application": "ChIP", "dilution": "", "species": ""}]
背景介绍
  • IL28B is a newly-discovered type III interferon, with antiviral, antiproliferative, and immunomodulatory functions. Type III IFNs share homology with IL-10 and the IL-10R2 receptor subunit, leading to the speculation that these cytokines might be evolutionarily related. It was recently found that polymorphisms in IFN-lambda-4 (another type III interferon) are associated with circulating IL28B, and higher plasma IL28B are associated with higher production of antibodies to HBV surface antigen. IL28B is associated with the extent of lupus activity, in particular with active serosal and cutaneous disease. Combined treatment with IL28B and sorafenib (a small molecule multikinase inhibitor) facilitates a synergistic effect on suppressing hepatocellular carcinoma cancer growth and promoting cell apoptosis in vitro and in vivo.

  • 配对推荐

    引用文献(0)

    评论(0)

      共 0 条
      • 1
      共计0页,前往

      关联产品推荐

        计算器

        email

        留言咨询